Utah Medical Products (UTMD) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $74.51, -0.55% vs the prior close of $74.92.
- Volume 44.31K shares, 1.3x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
UTMD dips 0.5% to $74.51. Closed at $74.51, -0.55% vs the prior close of $74.92. Day range $74.51–$75.12, opened at $74.99.
UTMD daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — UTMD dips 0.5% to $74.51
- Closed at $74.51, -0.55% vs the prior close of $74.92. Day range $74.51–$75.12, opened at $74.99.
- Volume was 44.31K shares, 1.3x its 50-day average of 35.31K.
- Price is +2.5% vs its 50-day average ($72.72) and +10.6% vs its 200-day average ($67.36).
- 52-week range $53.66–$76.89; today's close sits at 90% of that range, 3.1% below the 52-week high.
Oct 15, 2026 — UTMD ends flat (+0.2%) to $74.92, 3 up days in a row
- Closed at $74.92, +0.17% vs the prior close of $74.79. Day range $74.78–$75.33, opened at $74.90.
- Volume was 40.20K shares, 1.1x its 50-day average of 35.00K.
- Price is +3.1% vs its 50-day average ($72.63) and +11.4% vs its 200-day average ($67.26).
- 52-week range $53.66–$76.89; today's close sits at 92% of that range, 2.6% below the 52-week high.
- That makes 3 straight gains.
Oct 14, 2026 — UTMD ends flat (+0.1%) to $74.79
- Closed at $74.79, +0.11% vs the prior close of $74.71. Day range $74.20–$74.87, opened at $74.44.
- Volume was 22.70K shares, 0.6x its 50-day average of 35.21K.
- Price is +3.1% vs its 50-day average ($72.56) and +11.3% vs its 200-day average ($67.18).
- 52-week range $53.66–$76.89; today's close sits at 91% of that range, 2.7% below the 52-week high.
Oct 13, 2026 — UTMD rises 0.4% to $74.71
- Closed at $74.71, +0.40% vs the prior close of $74.41. Day range $73.89–$74.87, opened at $74.65.
- Volume was 38.30K shares, 1.1x its 50-day average of 34.74K.
- Price is +3.0% vs its 50-day average ($72.51) and +11.4% vs its 200-day average ($67.09).
- 52-week range $53.66–$76.89; today's close sits at 91% of that range, 2.8% below the 52-week high.
Oct 12, 2026 — UTMD ends flat (-0.2%) to $74.41 on 1.8x normal volume
- Closed at $74.41, -0.17% vs the prior close of $74.54. Day range $74.22–$75.18, opened at $74.58.
- Volume was 61.20K shares, 1.8x its 50-day average of 33.96K — unusually heavy trading.
- Price is +2.7% vs its 50-day average ($72.47) and +11.1% vs its 200-day average ($66.99).
- 52-week range $53.66–$76.89; today's close sits at 89% of that range, 3.2% below the 52-week high.
Oct 9, 2026 — UTMD rises 0.9% to $74.54
- Closed at $74.54, +0.89% vs the prior close of $73.88. Day range $73.75–$74.83, opened at $74.00.
- Volume was 45.30K shares, 1.3x its 50-day average of 33.65K.
- Price is +3.0% vs its 50-day average ($72.39) and +11.4% vs its 200-day average ($66.91).
- 52-week range $53.66–$76.89; today's close sits at 90% of that range, 3.1% below the 52-week high.
Oct 8, 2026 — UTMD rises 0.6% to $73.88
- Closed at $73.88, +0.59% vs the prior close of $73.45. Day range $73.47–$74.02, opened at $73.50.
- Volume was 32.70K shares, 1.0x its 50-day average of 33.62K.
- Price is +2.2% vs its 50-day average ($72.29) and +10.6% vs its 200-day average ($66.82).
- 52-week range $53.66–$76.89; today's close sits at 87% of that range, 3.9% below the 52-week high.
Oct 7, 2026 — UTMD dips 0.5% to $73.45 on 2.0x normal volume
- Closed at $73.45, -0.51% vs the prior close of $73.83. Day range $73.39–$74.21, opened at $74.00.
- Volume was 67.00K shares, 2.0x its 50-day average of 33.40K — unusually heavy trading.
- Price is +1.7% vs its 50-day average ($72.23) and +10.1% vs its 200-day average ($66.73).
- 52-week range $53.66–$76.89; today's close sits at 85% of that range, 4.5% below the 52-week high.
Oct 6, 2026 — UTMD rises 0.7% to $73.83 on 1.9x normal volume
- Closed at $73.83, +0.71% vs the prior close of $73.31. Day range $73.50–$74.18, opened at $73.50.
- Volume was 63.00K shares, 1.9x its 50-day average of 33.40K — unusually heavy trading.
- Price is +2.3% vs its 50-day average ($72.18) and +10.8% vs its 200-day average ($66.65).
- 52-week range $53.66–$76.89; today's close sits at 87% of that range, 4.0% below the 52-week high.
Oct 5, 2026 — UTMD dips 1.1% to $73.31
- Closed at $73.31, -1.11% vs the prior close of $74.13. Day range $73.22–$74.28, opened at $74.22.
- Volume was 33.90K shares, 1.0x its 50-day average of 34.24K.
- Price is +1.7% vs its 50-day average ($72.09) and +10.1% vs its 200-day average ($66.57).
- 52-week range $53.66–$76.89; today's close sits at 85% of that range, 4.7% below the 52-week high.
Oct 2, 2026 — UTMD ends flat (-0.3%) to $74.13
- Closed at $74.13, -0.30% vs the prior close of $74.35. Day range $74.13–$74.43, opened at $74.40.
- Volume was 19.60K shares, 0.6x its 50-day average of 35.37K — lighter than usual.
- Price is +3.0% vs its 50-day average ($71.97) and +11.5% vs its 200-day average ($66.49).
- 52-week range $53.66–$76.89; today's close sits at 88% of that range, 3.6% below the 52-week high.
UTMD latest news & SEC filings
Every SEC filing by or about UTMD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 · Form SC TO-I/A — SC TO-I/A filing
SC TO-I/A filing
Sep 29, 2026 · Form SC TO-I/A — SC TO-I/A filing
SC TO-I/A filing
Sep 25, 2026 · Form SC TO-C — SC TO-C filing
SC TO-C filing
Sep 24, 2026 · Form SC TO-C — SC TO-C filing
SC TO-C filing
Sep 24, 2026 · Form SC 13E3 — SC 13E3 filing
SC 13E3 filing
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 17, 2026 · Form SC TO-C — SC TO-C filing
SC TO-C filing
Aug 31, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $8.53M (prior year $9.95M) (-14.3% vs Jun 30, 2025)
- Diluted EPS: $0.84 (prior year $0.94) (-10.6% vs Jun 30, 2025)
Jul 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade UTMD
- Last results release: Jul 23, 2026 (8-K Item 2.02). Previous ones: Apr 23, 2026, Jan 29, 2026, Oct 23, 2025. Based on that rhythm, the next report is likely around Oct 22, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.75% (largest 2.9%). That is a relatively calm stock.
- Liquidity: about 37.58K shares (≈$2.80M) trade per day on average.
- 52-week position: $74.51 vs a range of $53.66–$76.89 (90% of the range).
- Dividends: last ex-dividend date Sep 17, 2026 ($0.31/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Aug 31, 2026; 10-Q Aug 12, 2026; 8-K Jul 23, 2026.
- Share count: 3.18M shares outstanding (Aug 11, 2026), -0.7% vs a year earlier.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
UTMD market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 74.99 | 75.12 | 74.51 | 74.51 | 44.31K |
| Oct 15, 2026 | 74.90 | 75.33 | 74.78 | 74.92 | 40.20K |
| Oct 14, 2026 | 74.44 | 74.87 | 74.20 | 74.79 | 22.70K |
| Oct 13, 2026 | 74.65 | 74.87 | 73.89 | 74.71 | 38.30K |
| Oct 12, 2026 | 74.58 | 75.18 | 74.22 | 74.41 | 61.20K |
| Oct 9, 2026 | 74.00 | 74.83 | 73.75 | 74.54 | 45.30K |
| Oct 8, 2026 | 73.50 | 74.02 | 73.47 | 73.88 | 32.70K |
| Oct 7, 2026 | 74.00 | 74.21 | 73.39 | 73.45 | 67.00K |
| Oct 6, 2026 | 73.50 | 74.18 | 73.50 | 73.83 | 63.00K |
| Oct 5, 2026 | 74.22 | 74.28 | 73.22 | 73.31 | 33.90K |
| Oct 2, 2026 | 74.40 | 74.43 | 74.13 | 74.13 | 19.60K |
| Oct 1, 2026 | 74.44 | 74.51 | 74.07 | 74.35 | 18.90K |
| Sep 30, 2026 | 74.95 | 74.95 | 74.04 | 74.05 | 30.00K |
| Sep 29, 2026 | 74.57 | 74.95 | 74.25 | 74.95 | 29.90K |
| Sep 28, 2026 | 74.18 | 74.54 | 73.75 | 74.49 | 31.40K |
| Sep 25, 2026 | 74.70 | 74.70 | 74.12 | 74.18 | 22.50K |
| Sep 24, 2026 | 75.50 | 75.55 | 74.30 | 74.75 | 42.10K |
| Sep 23, 2026 | 76.55 | 76.55 | 74.84 | 75.01 | 23.80K |
| Sep 22, 2026 | 74.77 | 76.89 | 74.75 | 76.66 | 56.20K |
| Sep 21, 2026 | 74.16 | 74.80 | 73.70 | 74.48 | 28.60K |
About Utah Medical Products
Utah Medical Products (UTMD) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in MIDVALE, UT. State of incorporation: UT. Fiscal year ends December 31. SEC CIK 706698.
UTMD board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Paul O Richins | Director | Jul 1, 2026 |
| Kevin Timken | Director | Dec 18, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Brian Koopman | Principal Financial Officer | May 29, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
UTMD financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $38.52M | — | 3.48 | $14.69M |
| Dec 31, 2024 | $40.90M | — | 3.96 | $14.83M |
| Dec 31, 2023 | $50.22M | — | 4.57 | $22.28M |
| Dec 31, 2022 | $52.28M | — | 4.52 | $21.15M |
| Dec 31, 2021 | $49.05M | — | 4.04 | $21.20M |
Latest balance sheet: total assets $124.57M, total liabilities $2.54M, cash $87.53M (as of Jun 30, 2026).
UTMD earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 23, 2026 | 8-K Item 2.02 (results) | $64.18 |
| Apr 23, 2026 | 8-K Item 2.02 (results) | $67.87 |
| Jan 29, 2026 | 8-K Item 2.02 (results) | $61.65 |
| Oct 23, 2025 | 8-K Item 2.02 (results) | $60.45 |
| Jul 24, 2025 | 8-K Item 2.02 (results) | $58.06 |
| Apr 29, 2025 | 8-K Item 2.02 (results) | $52.50 |
| Jan 28, 2025 | 8-K Item 2.02 (results) | $63.00 |
| Oct 29, 2024 | 8-K Item 2.02 (results) | $64.15 |
| Jan 30, 2024 | 8-K Item 2.02 (results) | — |
| Oct 26, 2023 | 8-K Item 2.02 (results) | — |
| Jul 25, 2023 | 8-K Item 2.02 (results) | — |
| Apr 25, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on UTMD
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.